Privia Health Group Inc (PRVA)
Pretax margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 27,870 | 24,116 | 24,569 | 24,301 | 29,021 | 28,154 | 15,435 | 1,726 | -18,580 | -41,513 | -50,325 | -237,901 | -218,506 | -195,249 | -174,109 | 25,050 | 23,463 |
Revenue (ttm) | US$ in thousands | 1,736,390 | 1,716,318 | 1,695,679 | 1,686,704 | 1,657,737 | 1,581,333 | 1,506,950 | 1,429,135 | 1,356,660 | 1,267,569 | 1,176,194 | 1,066,414 | 966,220 | 904,586 | 860,232 | 817,740 | 817,075 |
Pretax margin | 1.61% | 1.41% | 1.45% | 1.44% | 1.75% | 1.78% | 1.02% | 0.12% | -1.37% | -3.28% | -4.28% | -22.31% | -22.61% | -21.58% | -20.24% | 3.06% | 2.87% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $27,870K ÷ $1,736,390K
= 1.61%
The pretax margin of Privia Health Group Inc has displayed a fluctuating trend over the reporting periods. In December 2020, the pretax margin was 2.87%, indicating the company earned approximately $0.0287 in pre-tax profit for every dollar of revenue generated. This margin slightly increased to 3.06% by March 2021 before dropping significantly to -20.24% in June 2021, reflecting a period of loss before tax on each dollar of revenue.
The negative trend continued over the subsequent quarters, with the pretax margin deteriorating to -22.61% by December 2021. However, there was a notable improvement by the end of March 2023, with the pretax margin reaching 0.12%, indicating a return to profitability from the pre-tax perspective. This positive trajectory continued with the pretax margin improving to 1.61% by December 2024.
Overall, Privia Health Group Inc experienced a period of losses before tax in mid-2021, but managed to gradually recover and improve its pretax margin to a positive level by the end of 2023 and into 2024. This suggests the company implemented strategic measures to enhance profitability and operational efficiency over the analyzed period.
Peer comparison
Dec 31, 2024